BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31885339)

  • 1. Transurethral holmium laser resection and transurethral electrocision combined with intravesical epirubicin within 24 hours postoperatively for treatment of bladder cancer.
    Lu J; Xue Y; Shen F; Gu H; Liu H; Hou J; Miao H
    J Int Med Res; 2020 Jun; 48(6):300060519887267. PubMed ID: 31885339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study.
    Gudjónsson S; Adell L; Merdasa F; Olsson R; Larsson B; Davidsson T; Richthoff J; Hagberg G; Grabe M; Bendahl PO; Månsson W; Liedberg F
    Eur Urol; 2009 Apr; 55(4):773-80. PubMed ID: 19153001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy and feasibility of laser enucleation of bladder tumor versus transurethral resection of bladder tumor: a meta-analysis.
    Yang H; Wang N; Han S; Male M; Zhao C; Yao D; Chen Z
    Lasers Med Sci; 2017 Dec; 32(9):2005-2012. PubMed ID: 28831631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two instillations of epirubicin as prophylaxis for recurrence after transurethral resection of Ta and T1 transitional cell bladder cancer: a prospective, randomized controlled study.
    Saika T; Tsushima T; Nasu Y; Miyaji Y; Saegusa M; Takeda K; Kumon H
    World J Urol; 2010 Aug; 28(4):413-8. PubMed ID: 20054553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improvement of oncologic results of transurethral resection in the treatment of non-muscle-invasive bladder cancer].
    Zubkov AY; Nuriev IR; Sitdykova ME
    Urologiia; 2021 Jun; (3):110-113. PubMed ID: 34251111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical study of en bloc transurethral resection with 980 nm laser for treatment of primary non-muscle invasive bladder cancer.
    Tao W; Sun C; Yao Q; Fu K; Shan Y; Zhang Y; Xue B; Yang D
    J Xray Sci Technol; 2020; 28(3):563-571. PubMed ID: 32224536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective comparison of intra-arterial chemotherapy combined with intravesical chemotherapy and intravesical chemotherapy alone after transurethral resection with a thulium laser in high-risk non-muscle invasive bladder cancer.
    Sun F; Zhao R; Zhu Y; Cui D; Wang X; Han B; Liang S; Liu H; Sun X; Zhao F; Xu D; Xia S
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1099-1107. PubMed ID: 28421294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of En Bloc Transurethral Resection With 1.9 µm Vela Laser for Treatment of Non-Muscle-invasive Bladder Cancer.
    Xu H; Ma J; Chen Z; Yang J; Yuan H; Wang T; Liu J; Yang W; Ye Z
    Urology; 2018 Mar; 113():246-250. PubMed ID: 29198850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transurethral needle electrode resection and transurethral holmium laser resection of bladder cancer.
    Zhou Y; Zhang ZL; Luo MH; Yang H
    World J Surg Oncol; 2020 Jul; 18(1):166. PubMed ID: 32669107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EFFICACY OF DIFFERENT RESECTIONS ON NON-MUSCLE-INVASIVE BLADDER CANCER AND ANALYSIS OF THE OPTIMAL SURGICAL METHOD.
    Chen GF; Shi TP; Wang BJ; Wang XY; Zang Q
    J Biol Regul Homeost Agents; 2015; 29(2):465-70. PubMed ID: 26122238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Li C; Gao L; Zhang J; Yang X; Liu C
    Lasers Med Sci; 2020 Jul; 35(5):1025-1034. PubMed ID: 32006262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K
    Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epirubicin: a review of its intravesical use in superficial bladder cancer.
    Onrust SV; Wiseman LR; Goa KL
    Drugs Aging; 1999 Oct; 15(4):307-33. PubMed ID: 10582777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer.
    Naito S; Koga H; Yamaguchi A; Fujimoto N; Hasui Y; Kuramoto H; Iguchi A; Kinukawa N;
    J Urol; 2008 Feb; 179(2):485-90. PubMed ID: 18076918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
    Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S
    J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The best management of superficial bladder tumours: comparing TUR alone versus TUR combined with intravesical chemotherapy modalities?
    Altay B; Girgin C; Kefi A; Cikili N
    Int Urol Nephrol; 2000; 32(1):53-8. PubMed ID: 11057773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical epirubicin in the prophylaxis of superficial bladder cancer.
    Sengör F; Beysel M; Erdoğan K; Erol A; Tuzluoğlu D
    Int Urol Nephrol; 1996; 28(2):201-6. PubMed ID: 8836789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral resection of the bladder tumor.
    Huang B; Huang G; Li W; Chen L; Mao X; Chen J
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1781-1788. PubMed ID: 33222014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresection: single-center experience.
    Zhu Y; Jiang X; Zhang J; Chen W; Shi B; Xu Z
    Urology; 2008 Sep; 72(3):608-12. PubMed ID: 18649930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravesical instillation of epirubicin in the prophylactic treatment of recurrent superficial bladder cancer].
    Kobayashi M; Sugaya Y; Yuzawa M; Morita T; Kobayashi Y; Tokue A
    Hinyokika Kiyo; 1998 Dec; 44(12):861-4. PubMed ID: 10028430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.